Ephedra warning letters
This article was originally published in The Tan Sheet
Executive Summary
Universal Nutrition, which received FDA warning letter to discontinue ephedra athletic performance claims, says it has submitted response to agency pledging compliance and requesting clarification on some points; firm also has revised language on its Web site, labeling. New Brunswick, N.J.-based firm said it is debating whether or not to exit ephedra market. Other FDA letter recipients including American Body Building, Advanced Pharmaceuticals have issued similar responses to agency, which sent the letters in late February (1"The Tan Sheet" March 3, 2003, p. 8)...